Erhalten Sie die neuesten Stellenanzeigen für diese Suchanfrage kostenlos per E-Mail
Site Anzeigen bei AstraZeneca
27 Ergebnisse in 22msBeste Treffer
-
Senior Scientist (m/f/d), Computational Pathology Biomarker Lead (Oncology)
- AstraZeneca
- München, Bayern 80331, Germany
ABOUT ASTRAZENECA AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and...23. Mai -
Early Asset Management Lead (m/w/d) Oncology
- AstraZeneca
- Hamburg, Hamburg 20038, Germany
AstraZeneca hat sich zu einer global führenden Organisation im Bereich der biotechnologischen Forschung, Entwicklung und Gesundheitsversorgung in der...23. Mai -
Director, Head of CP Delivery Operations (m/f/d)
- AstraZeneca
- München, Bayern 80331, Germany
Director, Head of CP Data & Delivery Operations (m/f/d) ABOUT ASTRAZENECA AstraZeneca is a global, science-led, patient-focused biopharmaceutical...15. Mai -
Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d)
- AstraZeneca
- Munich, , Germany
Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d) Do you thrive at the intersection of AI innovation and clinical...20. Mai -
Director, Team Lead, Computational Pathology Biomarker Development (Oncology/BioPharmaceuticals) (m/f/d)
- AstraZeneca
- Munich, , Germany
Director, Team Lead, Computational Pathology Biomarker Development (Oncology/BioPharmaceuticals) (m/f/d) Do you thrive at the intersection of AI...28. Mai -
Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d)
- AstraZeneca
- München, Bayern 80331, Germany
Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d) Do you thrive at the intersection of AI innovation and clinical...22. Mai -
Director, Team Lead, Computational Pathology Biomarker Development (Oncology/BioPharmaceuticals) (m/f/d)
- AstraZeneca
- München, Bayern 80331, Germany
Director, Team Lead, Computational Pathology Biomarker Development (Oncology/BioPharmaceuticals) (m/f/d) Do you thrive at the intersection of AI...22. Mai